 with 14.9% in
the surgical group, an absolute risk reduction of 11.6%.
In both studies, the risk of stroke in the medical arm
and, therefore, the beneÔ¨Åt of CEA, increased with an
increasing degree of stenosis. The results of these trials
established CEA as the treatment of choice for patients

with severe carotid stenosis and have been widely
accepted throughout the medical community. The